NICE recommends new triple therapy for multiple myeloma patients
March 19, 2021Medical Communications NHS England, NICE, oncology
A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a …
AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA
March 19, 2021Medical Communications AstraZeneca, COVID-19, EMA, Vaccine
AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …
AstraZeneca & MSD ovarian cancer drug combination approved by NICE
March 19, 2021Medical Communications AstraZeneca, MSD, NICE, oncology
A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian …
Antion launch new technology for cancer and tumour treatments
March 18, 2021Cancer, action, blood cancer, myeloma
Antion Biosciences has launched a new T-cell technology platform to help with the development of new curative therapies for diseases …
GSK starts Phase III study for severe asthma treatment
March 18, 2021GSK, asthma, phase III
GSK has announced today that the first patient has been dosed in part of their Phase III clinical trial investigating …
Florida woman gives birth to first-known baby born with COVID-19 antibodies
March 18, 2021COVID-19, Moderna, Vaccine
A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …
NICE recommends Daiichi Sankyo’s cholesterol-lowering treatments for NHS England use
March 18, 2021Daiichi Sankyo, NICE, cholesterol
NICE has recommended Daiichi Sankyo’s bempedoic acid and bempedoic acid/ezetimibe for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed …
AstraZeneca leukaemia treatment recommended for NHS use
March 18, 2021AstraZeneca, NHS
AstraZeneca has announced today that its oral targeted cancer therapy, Calquence (acalabrutinib), has been recommended by NICE for routine use …
Pharmafile.com’s weekly COVID-19 news round-up
March 17, 2021Research and Development COVID-19, covid-19 roundup, news roundup
The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial
March 17, 2021Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis
Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
Axol Bioscience and CENSO Biotechnologies enter merger agreement
March 17, 2021Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience
Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
PEP-Therapy and Institut Curie’s cancer drug trial approved in France
March 17, 2021Research and Development Cancer, France, Pep-therapy
PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …
Medicago & GSK start plant-derived COVID-19 vaccine trial
March 17, 2021Research and Development COVID-19, GSK
Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
Johnson & Johnson’s arthritis drug shows promising results in Phase III trial
March 16, 2021Manufacturing and Production Janssen, Johnson & Johnson, PSA, Tremfya, arthritis
Johnson & Johnson’s TREMFYA treatment for active Psoriatic Arthritis (PsA) has returned positive results in its Phase III trial.
Roche and PTC’s SMA treatment shows positive trial results
March 16, 2021Manufacturing and Production PTC, PTC Therapeutics, Roche, sma, spinal muscular atrophy
Roche and PTC Therapeutics’s Evrysdi treatment for children and adults with Type 2 or Type 3 spinal muscular atrophy (SMA) …
AstraZeneca vaccine suspended in 11 European countries
March 16, 2021Manufacturing and Production AstraZeneca
Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine. France, Germany, Italy, and …
Gilead and MSD partner to develop and commercialise two-drug HIV regimen
March 16, 2021Manufacturing and Production Gilead, HIV, MSD
Gilead and MSD, known as Merck in the US and Canada, have entered into an agreement to co-develop and co-commercialise …
Perception and Otsuka enter collaboration and licensing deal for depression drug candidate
March 16, 2021Manufacturing and Production CNS, Otsuka Pharmaceutical, Perception Neuroscience, depression
Perception Neuroscience and Otsuka Pharmaceutical have announced a collaboration and licensing agreement for the development and commercialisation of Perception’s lead …
Ocuphire’s pupil dilation treatment shows promising Phase III trial results
March 15, 2021Sales and Marketing Ocuphire, eye treatment, nyxol
Ocuphire Pharma’s Nyxol treatment for pharmacologically-induced pupil dilation (mydriasis) has met its primary and secondary endpoints in its Phase III …
Newron and Zambon to collaborate on Parkinson’s dyskinesia drug trial
March 15, 2021Sales and Marketing Newron Pharmaceuticals, Parkinson's, Zambon
Newron Pharmaceuticals and its partner Zambon have announced an agreement for a potentially pivotal study to evaluate the efficacy of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
